For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Happy father with daughter on his shoulders under a clear blue sky
Therapeutic areas

Discover our medicines

Close up on the hands of a laboratory technician wearing blue gloves preparing a sample with pipette
Research and development

Explore our science

HCP wearing a medical coat pulling a cart bicycle in rural african village
ESG

Learn about our impact

Two business people smiling in a modern and bright room
Careers

Join our team

Latest news

Jul 17, 2026

  • Story

Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next

Jul 17, 2026

  • Press release

Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN

Jul 06, 2026

  • Press release

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
All news
Person holding baby outdoors near gardening plants on a sunny day.

30 years of Novartis, powered by 250 years of innovation

Rooted in a legacy of scientific discovery, Novartis continues to advance breakthrough medicines that redefine the future of care for patients.

Learn more about the 30 years of Novartis
NIBR Operator in Cambridge, Massachusetts
Live. Magazine

The Novartis story

30 years of innovation and engagement.
The Novartis story
Business people walking on the Novartis Basel campus

Annual reporting suite

Explore and download our Annual Report 2025, Report on Nonfinancial Matters 2025 and other reporting documents.

Learn more

Resource links

About Novartis
Patients and caregivers
Healthcare professionals
Clinical trials
Pipeline
Products